Nobilis Salenvac
Revised: October 2010
AN: 01657/2009
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
Nobilis Salenvac
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Per ml:
Active substance:
Formalin killed cells of Salmonella Enteritidis phage type 4 2 x 109
Adjuvant:
Alhydrogel, (containing 3% aluminium hydroxide) 250 mg
Excipient:
Thiomersal (preservative) 0.13 mg
For a full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Suspension for injection.
4. CLINICAL PARTICULARS
4.1 Target species
Chickens: - layers and breeders
4.2 Indications for use, specifying the target species
For the active immunisation of poultry against Salmonella Enteritidis, to reduce shedding of S. Enteritidis into the environment.
Antibodies against S. Enteritidis develop within a few weeks of the second vaccination.
A second peak is achieved shortly after a third vaccination. These antibodies have been shown to persist for at least 60 weeks. Passive immunity will be transferred via the egg to the progeny for at least 57 weeks.
4.3 Contraindications
Do not use in laying birds.
4.4 Special warnings
None.
4.5 Special precautions for use
Special precautions for use in animals
Cross reactions in tests for S. Pullorumare possible but at a low level and may be distinguished from true infection when dilutions of sera are tested, or following heat inactivation. Where serology is positive for S. Pullorum, the diagnosis should be confirmed by bacteriology. Hygienic measures and monitoring should not be neglected.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
In the case of accidental self injection, seek medical advice immediately and show the package insert or the label to the physician.
4.6 Adverse reactions (frequency and seriousness)
The vaccine contains an adjuvant and may cause a temporary nodule at the site of injection, up to 5 mm in diameter, lasting for up to 2 to 3 days.
4.7 Use during pregnancy, lactation or lay
Do not use in laying birds.
4.8 Interaction with other medicinal products and other forms of interaction
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
4.9 Amounts to be administered and administration route
Dose
0.1ml to day-old chicks followed by 0.5ml at 4 weeks of age and a booster dose of 0.5ml at 18 weeks of age.
Administration is by intramuscular injection.
The recommended vaccination schedule has been shown under experimental conditions to reduce diarrhoea, excretion of SalmonellaEnteritidis PT4, infection of certain tissues and egg contamination by SalmonellaEnteritidis PT4 following challenge. No data are available on these effects in field conditions. Experimentally, it has also been shown that a schedule of two doses of 0.5ml by intramuscular injection, administered respectively at 12 and 16 weeks of age, can produce similar results, but the contamination of eggs has only been investigated in a study involving small numbers.
The use of an automatic vaccinator is recommended. Since the bottle is non-collapsible, a vaccinator with a vented draw-off spike or similar device must be used. The instructions supplied with such equipment should be noted and care should be taken to ensure the delivery of the full dose, particularly with the final few doses from the bottle.
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
The vaccine has been shown to be safe at twice the recommended dose. No effects other than those recorded following administration of one dose were observed.
4.11 Withdrawal period
Zero days.
5. IMMUNOLOGICAL PROPERTIES
To stimulate active immunity against Salmonella Enteritidis
Inactivated bacterial vaccine. ATC vet code: QI01AB01
6. PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Aluminium hydroxide gel
Tris
Maleic acid
Sodium chloride
Formaldehyde
Thiomersal
Water for injection
6.2 Incompatibilities
Do not mix with any other veterinary medicinal product.
6.3 Shelf life
Unopened: 3 years.
Use broached vials immediately.
Partly used packs should be safely destroyed at the end of a day's operations as puncture of the rubber caps could cause accidental contamination of the remaining contents.
6.4. Special precautions for storage
Store and transport refrigerated (2 C – 8 C)
Protect from light.
Do not freeze.
6.5 Nature and composition of immediate packaging
Carton box with low density multidose polyethylene containers of 250ml and 500ml sealed with an aluminium cap over a rubber stopper. Containers and closures conform to Ph.Eur.
Not all pack sizes may be marketed.
6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
Any unused product or waste material should be disposed of in accordance with national requirements.
7. MARKETING AUTHORISATION HOLDER
Intervet UK Ltd.
Walton Manor
Walton
Milton Keynes
Bucks. MK7 7AJ
8. MARKETING AUTHORISATION NUMBER
Vm 01708/4389
9. DATE OF RENEWAL OF THE AUTHORISATION
20 June 2010
10 DATE OF REVISION OF THE TEXT
October 2010
Page 4 of 4